Photonic Bone Density Spectroscopy Device Market Global Report 2026

The photonic bone density spectroscopy device market size has grown strongly in recent years. It will grow from $1.17 billion in 2025 to $1.26 billion in 2026 at a compound annual growth rate (CAGR) of 8%. The growth in the historic period can be attributed to rising prevalence of osteoporosis and bone-related disorders, increasing demand for non-invasive diagnostic imaging solutions, advancements in optical and photonic medical technologies, expansion of diagnostic healthcare infrastructure, and growing awareness of preventive bone health screening.

The photonic bone density spectroscopy device market size is expected to see strong growth in the next few years. It will grow to $1.73 billion in 2030 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to integration of AI-based diagnostic imaging systems, increasing adoption of radiation-free medical imaging technologies, expansion of portable and point-of-care diagnostic devices, rising investment in precision medicine and early disease detection, and growing demand for cloud-enabled healthcare data sharing and analytics. Major trends in the forecast period include AI-enabled photonic bone density diagnostic analytics for early osteoporosis detection, non-ionizing laser-based multi-spectral bone assessment systems, portable photonic spectroscopy devices for point-of-care bone health screening, cloud-connected bone density imaging platforms for remote diagnostics, and high-precision multi-wavelength photonic bone quality mapping technologies.

The increasing demand for non-invasive diagnostics is expected to drive the growth of the photonic bone density spectroscopy device market in the coming years. Non-invasive diagnostics are medical evaluation methods that assess a patient’s health condition without penetrating the skin, entering body cavities, or requiring surgical procedures. The demand for non-invasive diagnostics is rising due to the rapid global aging of the population, as a growing proportion of older adults develop chronic musculoskeletal conditions such as osteoporosis that require repeated, long-term monitoring without the risks associated with invasive procedures. Photonic bone density spectroscopy supports non-invasive diagnostics by using light-based spectroscopic techniques to accurately and painlessly measure bone mineral density, enabling broad screening without patient discomfort or exposure to radiation. For instance, in May 2023, according to the National Health Service, a UK-based government department, the number of brain magnetic resonance imaging (MRI) activities referred by general practitioners increased from 8,695 in January 2022 to 8,745 in January 2023. Therefore, the increasing demand for non-invasive diagnostics is driving the growth of the photonic bone density spectroscopy device market.

Major companies operating in the photonic bone density spectroscopy device market are focusing on developing advanced imaging solutions such as photon-counting spectral CT systems to enhance bone quality assessment, diagnostic accuracy, and point-of-care imaging capabilities. Photon-counting spectral CT systems are advanced diagnostic technologies that detect and measure individual X-ray photons to produce highly detailed images with improved tissue and bone characterization. For instance, in June 2023, Hospital for Special Surgery (HSS), a US-based academic medical center specializing in musculoskeletal health, partnered with MARS Bioimaging Limited (MARS), a New Zealand-based medical device and technology company, to introduce a spectral imaging photon-counting point-of-care CT scanner system designed for musculoskeletal and orthopedic applications. The system uses photon-counting detector technology to provide high-resolution spectral imaging, enabling enhanced visualization of bone structures, improved diagnostic accuracy, and more efficient clinical evaluation in point-of-care settings.

In November 2024, Echolight S.p.A., an Italy-based company that manufactures and commercializes radiation-free bone densitometry devices, partnered with Siemens Healthineers to expand global distribution of its radiation-free ultrasound bone density diagnostic technology. Through this partnership, Siemens Healthineers will distribute Echolight’s radiation-free bone density devices as part of its women’s health portfolio, enabling wider global adoption of non-ionizing bone health diagnostics and strengthening access to advanced spectroscopy-based bone assessment technologies. Siemens Healthineers AG is a Germany-based medical imaging and diagnostics solutions provider that serves as a distributor and ecosystem partner for photonic (radiation-free ultrasound) bone density technologies.

Major companies operating in the photonic bone density spectroscopy device market are Hamamatsu Photonics K.K., HORIBA Ltd., Ocean Insight, Si-Ware Systems, Avantes B.V., Wasatch Photonics.

North America was the dominant region in the photonic bone density spectroscopy device market in 2025. Asia-Pacific is expected to be the rapidly expanding region in the forecast period. The regions covered in photonic bone density spectroscopy device report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the photonic bone density spectroscopy device market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The photonic bone density spectroscopy device market consists of sales of photonic bone scanners, spectroscopy analyzers, near-infrared light emitters, optical fiber sensors, laser diode modules, photodetector arrays, and signal processing units. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The photonic bone density spectroscopy device market research report is one of a series of new reports that provides photonic bone density spectroscopy device market statistics, including photonic bone density spectroscopy device industry global market size, regional shares, competitors with a photonic bone density spectroscopy device market share, detailed photonic bone density spectroscopy device market segments, market trends and opportunities, and any further data you may need to thrive in the photonic bone density spectroscopy device industry. This photonic bone density spectroscopy device market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

This product will be delivered within 1-3 business days.